Page last updated: 2024-08-25

efaroxan and Allodynia

efaroxan has been researched along with Allodynia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caselli, G; Ferrari, F; Lanza, M; Menghetti, I; Tremolada, D1
Cahill, CM; Grenier, P; Jhamandas, K; Milne, B; Sutak, M1
Jesse, CR; Nogueira, CW; Savegnago, L1

Other Studies

3 other study(ies) available for efaroxan and Allodynia

ArticleYear
Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats.
    British journal of pharmacology, 2014, Volume: 171, Issue:15

    Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Binding Sites; Drug Synergism; Female; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Male; Morphine; Naloxone; Narcotic Antagonists; Pain, Postoperative; Quinazolines; Rats, Sprague-Dawley; Yohimbine

2014
Stereo-selective inhibition of spinal morphine tolerance and hyperalgesia by an ultra-low dose of the alpha-2-adrenoceptor antagonist efaroxan.
    European journal of pharmacology, 2013, Feb-28, Volume: 702, Issue:1-3

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Analgesics; Animals; Benzofurans; Clonidine; Drug Tolerance; Hot Temperature; Hyperalgesia; Imidazoles; Injections, Spinal; Male; Morphine; Pain; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Touch

2013
Caffeine and a selective adenosine A(2B) receptor antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice.
    Neuroscience letters, 2008, May-09, Volume: 436, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Benzene Derivatives; Benzofurans; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Imidazoles; Injections, Intraperitoneal; Male; Mice; Neuroprotective Agents; Organoselenium Compounds; Pain Measurement; Phosphodiesterase Inhibitors; Pyrimidines; Triazoles; Xanthines

2008